scispace - formally typeset
J

Juan P. Casas

Researcher at VA Boston Healthcare System

Publications -  237
Citations -  29858

Juan P. Casas is an academic researcher from VA Boston Healthcare System. The author has contributed to research in topics: Population & Genome-wide association study. The author has an hindex of 78, co-authored 217 publications receiving 26495 citations. Previous affiliations of Juan P. Casas include Veterans Health Administration & Industrial University of Santander.

Papers
More filters
Journal ArticleDOI

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Stephen Sawcer, +265 more
- 10 Aug 2011 - 
TL;DR: In this article, a collaborative GWAS involving 9,772 cases of European descent collected by 23 research groups working in 15 different countries, they have replicated almost all of the previously suggested associations and identified at least a further 29 novel susceptibility loci.
Journal ArticleDOI

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

Georg Ehret, +391 more
- 06 Oct 2011 - 
TL;DR: A genetic risk score based on 29 genome-wide significant variants was associated with hypertension, left ventricular wall thickness, stroke and coronary artery disease, but not kidney disease or kidney function, and these findings suggest potential novel therapeutic pathways for cardiovascular disease prevention.
Journal ArticleDOI

A Genome-Wide Association Study Identifies New Psoriasis Susceptibility Loci and an Interaction Between HLA-C and ERAP1

Amy Strange, +85 more
- 01 Nov 2010 - 
TL;DR: These findings implicate pathways that integrate epidermal barrier dysfunction with innate and adaptive immune dysregulation in psoriasis pathogenesis and report compelling evidence for an interaction between the HLA-C and ERAP1 loci.
Journal ArticleDOI

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

Daniel I. Swerdlow, +115 more
- 31 Mar 2012 - 
TL;DR: IL6R blockade could provide a novel therapeutic approach to prevention of coronary heart disease that warrants testing in suitably powered randomised trials and could help to validate and prioritise novel drug targets or to repurpose existing agents and targets for new therapeutic uses.

The UK10K project identifies rare variants in health and disease

Klaudia Walter, +241 more
TL;DR: The contribution of rare and low-frequency variants to human traits is largely unexplored as mentioned in this paper, but the contribution of these variants to the human traits has not yet been fully explored.